StockData
Galectin Therapeutics Inc logo

Galectin Therapeutics Inc (GALT) stock

GALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.91−0.11 (-3.64%)

Close on Nov 17, 2026Market cap $293.47MP/E –Yield –

Galectin Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Galectin Therapeutics's price to book ratio was 103.0× on Apr 29, 2022, against 11.2× a year earlier. Over the last 5 years it ranged from 2.5× to 258.8×, with a median of 13.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 2022103.0×+86.7
2021Dec 31, 202116.3×+12.0
2020Dec 31, 20204.3×+0.9
2019Dec 31, 20193.4×−16.1
2018Dec 31, 201819.5×−106.2
2017Dec 29, 2017125.7×+122.9
2016Dec 30, 20162.8×−0.3
2015Dec 31, 20153.1×−0.2
2014Dec 31, 20143.3×−106.4
2013Dec 31, 2013109.7×+99.0
2012Dec 31, 201210.7×−79.0
2011Dec 30, 201189.7×–

More Galectin Therapeutics figures

See a number that looks wrong?